
Bafna Pharmaceuticals Investor Relations Material
Latest events

Q4 24/25
26 May, 2025

Q3 2025
6 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Bafna Pharmaceuticals Limited
Access all reports
Bafna Pharmaceuticals Limited is a pharmaceutical company engaged in the development, manufacturing, and marketing of generic and branded pharmaceutical formulations. The company produces a range of dosage forms including tablets, capsules, and oral liquids across various therapeutic segments. It supplies its products to both domestic and international markets, with a focus on regulated and semi-regulated regions. Bafna Pharmaceuticals Limited also offers contract manufacturing services and maintains compliance with global quality standards. The company is headquartered in Chennai, India, and its shares are listed on the BSE.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
BAFNAPH
Country
🇮🇳 India